IL-23 is a factor involved in the development of autoimmune diseases, such as multiple sclerosis (MS), rheumatoid arthritis (RA), and systemic lupus erythematosus; it carries out its activity by stimulating and activating the pathogenic Th17 cells. Here, IL37 is linked to systemic lupus erythematosus.